“[Cost Per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis]”. Farmeconomia. Health economics and therapeutic pathways 25, no. 1 (March 28, 2024). Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1554.